Leon Regensberg

1.6k total citations
15 papers, 1.2k citations indexed

About

Leon Regensberg is a scholar working on Infectious Diseases, Virology and Economics and Econometrics. According to data from OpenAlex, Leon Regensberg has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Economics and Econometrics. Recurrent topics in Leon Regensberg's work include HIV/AIDS Research and Interventions (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (7 papers). Leon Regensberg is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (7 papers). Leon Regensberg collaborates with scholars based in South Africa and United States. Leon Regensberg's co-authors include Michael Hislop, Gary Maartens, Jean B. Nachega, David W. Dowdy, Richard E. Chaisson, Hoàng Dũng Nguyễn, Mark F. Cotton, Saad B. Omer, Melanie Lo and Rory Leisegang and has published in prestigious journals such as Annals of Internal Medicine, PLoS Medicine and AIDS.

In The Last Decade

Leon Regensberg

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leon Regensberg South Africa	9	1.2k	494	337	304	176	15	1.2k
Geoffrey Fatti South Africa	21	945 0.8×	272 0.6×	398 1.2×	415 1.4×	117 0.7×	60	1.1k
Eyerusalem K. Negussie Switzerland	13	959 0.8×	187 0.4×	461 1.4×	538 1.8×	94 0.5×	15	1.1k
Carroll Child United States	9	844 0.7×	252 0.5×	186 0.6×	392 1.3×	216 1.2×	16	1.0k
Tsitsi Apollo Zimbabwe	19	841 0.7×	221 0.4×	453 1.3×	343 1.1×	64 0.4×	56	975
Tafireyi Marukutira United States	12	621 0.5×	135 0.3×	314 0.9×	256 0.8×	93 0.5×	33	737
Karl‐Günter Technau South Africa	24	1.4k 1.2×	673 1.4×	396 1.2×	471 1.5×	305 1.7×	80	1.6k
Richard Conviser United States	13	805 0.7×	171 0.3×	269 0.8×	564 1.9×	172 1.0×	31	949
Nafuna Wamai Uganda	10	1.0k 0.9×	203 0.4×	539 1.6×	509 1.7×	146 0.8×	10	1.1k
Shannon Hader United States	19	949 0.8×	260 0.5×	334 1.0×	670 2.2×	115 0.7×	33	1.1k
Irene Mukui Kenya	15	624 0.5×	214 0.4×	219 0.6×	316 1.0×	74 0.4×	43	697

Countries citing papers authored by Leon Regensberg

Since Specialization

Citations

This map shows the geographic impact of Leon Regensberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Regensberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Regensberg more than expected).

Fields of papers citing papers by Leon Regensberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon Regensberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Regensberg. The network helps show where Leon Regensberg may publish in the future.

Co-authorship network of co-authors of Leon Regensberg

This figure shows the co-authorship network connecting the top 25 collaborators of Leon Regensberg. A scholar is included among the top collaborators of Leon Regensberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leon Regensberg. Leon Regensberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Meintjes, Graeme, et al.. (2015). Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study. AIDS Research and Therapy. 12(1). 39–39. 21 indexed citations

Leisegang, Rory, Gary Maartens, Michael Hislop, Leon Regensberg, & Susan Cleary. (2010). Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings. BMC Health Services Research. 10(S1). S3–S3. 11 indexed citations

Nachega, Jean B., Rory Leisegang, David Bishai, et al.. (2010). Association of Antiretroviral Therapy Adherence and Health Care Costs. Annals of Internal Medicine. 152(1). 18–25. 58 indexed citations

Nachega, Jean B., Michael Hislop, Hoàng Dũng Nguyễn, et al.. (2009). Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(1). 65–71. 346 indexed citations

Leisegang, Rory, Susan Cleary, Michael Hislop, et al.. (2009). Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis. PLoS Medicine. 6(12). e1000189–e1000189. 45 indexed citations

Nachega, Jean B., Michael Hislop, David W. Dowdy, et al.. (2008). Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 22(16). 2117–2125. 62 indexed citations

Nachega, Jean B., Michael Hislop, David W. Dowdy, et al.. (2008). Efavirenz versus nevirapine-based initial treatment of HIV infection: Clinical and virological outcomes in Southern African adults (AIDS (2008) 22, 16, (2117-2126)). 22(17). 1 indexed citations

Bisson, Gregory P., Robert Gross, Scarlett L. Bellamy, et al.. (2008). Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy. PLoS Medicine. 5(5). e109–e109. 131 indexed citations

Sinanovic, Edina, et al.. (2007). HIV and AIDS, STI and TB in the private sector : health care delivery. South African Health Review. 2007(1). 201–211. 4 indexed citations

10.

Nachega, Jean B., Michael Hislop, David W. Dowdy, et al.. (2007). Adherence to Nonnucleoside Reverse Transcriptase Inhibitor–Based HIV Therapy and Virologic Outcomes. Annals of Internal Medicine. 146(8). 564–573. 301 indexed citations

11.

Nachega, Jean B., Michael Hislop, David W. Dowdy, et al.. (2006). Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(1). 78–84. 227 indexed citations

12.

Regensberg, Leon, et al.. (2004). Enrolment experience and the measurement of survival in a private sector HIV/AIDS disease management programme. Southern African Journal of HIV Medicine. 5(2). 15–15. 1 indexed citations

13.

Regensberg, Leon, et al.. (2003). A report back on more than four years of HIV/AIDS disease management in southern Africa. Southern African Journal of HIV Medicine. 4(1). 7–7. 7 indexed citations

14.

Regensberg, Leon, et al.. (2000). Prevention of vertical transmission of human immunodeficiency type 1 virus in a managed care setting.. PubMed. 90(11). 1093–4. 2 indexed citations

15.

Jackson, Terry, et al.. (1994). Control of an amoebiasis outbreak in the Philippi area near Cape Town.. PubMed. 84(7). 389–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact